Abstract: Thresholds b1, b2, b3, and b4 are set in the luminance of a raw image. In an image 84a of the lowermost layer, the region in which the luminance is equal to or higher than b1 is left. In an image 84b over it, the region in which the luminance is equal to or higher than b2 is left. In an image 84c over it, the region in which the luminance is equal to or higher than b3 is left. In an image 84d of the uppermost layer, the region in which the luminance is equal to or higher than b4 is left. In each of these images, the alpha value of the other region is set to 0. The images are integrated with the color information of the raw image to generate final slice images. A display image is generated by stacking the generated slice images sequentially from the lowermost layer at predetermined intervals and performing drawing according to the point of sight.

Abstract: A liquid developer includes an insulating liquid and toner particles which are dispersed in the insulating liquid and contain a resin and a coloring agent. The resin contains a first resin which is a crystalline urethane-modified polyester resin resulting from increase in chain length of a component derived from a polyester resin by a compound containing an isocyanate group. The toner particles have a peak in a DSC curve in temperature increase at 55° C. or higher, have a peak in the DSC curve in temperature decrease at 30° C. or higher, and have a storage elastic modulus at 80° C., not lower than 1×105 Pa and not higher than 1×107 Pa.

Abstract: A liquid developer includes an insulating liquid and toner particles which are dispersed in the insulating liquid and contain a resin and a coloring agent. The resin contains a first resin which is a resin containing a component derived from a crystalline polyester resin. The coloring agent contains carbon black and nigrosine. The toner particles have a peak at not lower than 30° C. and not higher than 50° C. in a DSC curve in temperature decrease.

Abstract: A liquid developer set of the present invention includes a first liquid developer including an insulating liquid and first toner particles and a second liquid developer including an insulating liquid and second toner particles, the first toner particles include carbon black and a first resin, the second toner particles include a coloring agent other than carbon black and a second resin, without including carbon black, the first resin and the second resin each include a hydrocarbon long chain which is a hydrocarbon group having a carbon number of 8 to 30, and a mass ratio of the hydrocarbon long chain to the first toner particles is higher than a mass ratio of the hydrocarbon long chain to the second toner particles.

Abstract: The present invention provides a novel method for detection of liver cancer. This method detects high-sensitively, high-specifically, simply and accurately liver cancer, especially that in early stage by identifying and/or quantifying methylation on particular genes and/or their DNA fragments in clinical specimens, and by combining said methylated DNA values with existing tumor marker values and/or DNA amounts in blood. This invention also detects a precancerous lesion, detects a risk of recurrence after treatment of liver cancer, detects malignancy of liver cancer and monitors progression of liver cancer with time by the same method. As for particular genes, BASP1 gene, SPINT2 gene, APC gene, CCND2 gene, CFTR gene, RASSF1 gene and SRD5A2 gene are mentioned.

Abstract: A liquid developer includes an insulating liquid and toner particles dispersed in the insulating liquid. The insulating liquid has a flash point not lower than 100° C. The toner particles contain a resin, and the resin contains 80 mass % or more of a first resin containing a component derived from a polyester resin. A solid content of the liquid developer corresponding to a portion of the liquid developer excluding the insulating liquid satisfies relation of G?(T0)/G?(T0+10)?10 (50° C.?T0?70° C.), where G?(T0) represents a storage elastic modulus at a temperature T0 (° C.) and G?(T0+10) represents a storage elastic modulus at a temperature (T0+10) (° C.).

Abstract: In an image processing apparatus, a sensor output data acquisition unit acquires data of layered image information from a sensor group. A slice image generation unit generates data of a two-dimensional image for each slice plane surfaces in which distribution is acquired. An image axis conversion unit generates similar data of a two-dimensional image for a plurality of plane surfaces that are perpendicular to an axis different from a sensor axis. A slice image management unit of a display processing unit manages a slice image that is used for drawing according to the position of a viewpoint or the like. Memory for drawing sequentially stores data of an image necessary for drawing. An additional object image storage unit stores image data of an object that is additionally displayed such as a cursor or the like. An image drawing unit draws a three-dimensional object using data of the slice image.

Abstract: There is provided an information processing apparatus including a display controller that controls a display of an object to be displayed such that when the object to be displayed is displayed stereoscopically in accordance with 3D image data that can be displayed stereoscopically, a display format of the object to be displayed positioned outside a fusional area of an observer is different from a display format of the object to be displayed positioned inside the fusional area.

Abstract: A toner including: a binder resin; a releasing agent; and a colorant, wherein the binder resin contains a crystalline polyester resin and a non-crystalline polyester resin, wherein the releasing agent has an endothermic peak temperature of 60° C. to 80° C. at the second temperature rising in differential scanning calorimetry, and wherein the releasing agent is an ester wax which satisfies the following expressions (1) and (2): 1.1 Pa·s??*a?2.0 Pa·s . . . Expression (1) 0.001??*b/?*a?1.00 . . . Expression (2) where in Expressions (1) and (2), ?*a denotes a complex viscosity (Pa·s) determined by measuring a dynamic viscoelasticity of the releasing agent at a measurement frequency of 6.28 rad/s, and ?*b denotes a complex viscosity (Pa·s) determined by measuring a dynamic viscoelasticity of the releasing agent at a measurement frequency of 62.8 rad/s.

Abstract: A first GPU is provided with a digital video output terminal (Vout terminal) for connection to an external source. A digital video signal output from the Vout terminal is provided to a display device via a HDMI. The first GPU and a second GPU are connected to each other via a data bus for bidirectional data exchange. The second GPU applies a predetermined rendering process on data provided from the first GPU via a data input and output interface. The rendered data is returned to the first GPU via the data input and output interface. The first GPU processes the data returned from the second GPU as necessary and outputs a digital video signal via the Vout terminal and the HDMI.

Abstract: The present invention relates to a scoring system for the prediction of cancer recurrence by selecting genes and/or proteins whose expression patterns associated with recurrence of cancer, and generating formulae with the selected genes and/or proteins for the prediction of cancer recurrence. The present invention relates to a kit for determining the likelihood of recurrence of cancer, comprising DNA chip, oligonucleotide chip, protein chip, peptides, antibodies, probes and primers that are necessary for effecting DNA microarrays, oligonucleotide microarrays, protein arrays, northern blotting, in situ hybridization, RNase protection assays, western blotting, ELISA assays, reverse transcription polymerase-chain reaction to examine the expression of at least 2, 4, 6, 10, 12 or more genes and/or proteins, that are indicative of cancer recurrence.

Abstract: To provide an image processor that is capable of presenting images in which a character object is moved smoothly and naturally as a user intends it to be, regardless of the change in shape of an object.

Abstract: A pixel set formation unit in an image analysis unit of an image processing device forms pixel sets from original images subject to analysis. A principal analysis unit of the image analysis unit performs principal component analysis in units of pixel sets. A synthesis unit synthesizes results of analysis in units of pixel sets so as to generate images of eigenvectors of a size of the original images. An image generation unit displays the images of the eigenvectors and stores data for an image generated by using the images of the eigenvectors in a generated image storage unit.

Abstract: A rendering process for rendering an image frame and a postprocess for adapting the image frame to a display are separated. A rendering processing unit 42 generates an image frame sequence by performing rendering at a predetermined frame rate regardless of a condition that the image frame should meet for output to the display. A postprocessing unit 50 subjects the image frame sequence generated by the rendering processing unit to a merge process so as to generate and output an updated image frame sequence that meets the condition. Since the rendering process and the postprocess are separated, the image frame sequence can be generated regardless of the specification of the display such as resolution and frame rate of the display.

Abstract: A hydrazine-fixing group such as a ketone group, a formyl group, a chlormethyl group or an amide group, which is capable of releasably fixing hydrazine, is introduced into a side chain of a synthetic resin, and hydrazine is fixed to the hydrazine-fixing group. Since a hydrazine storage resin of the present invention has a hydrazine-releasable group capable of releasing hydrazine, it is able to store hydrazine stably. In addition, hydrazine can be supplied by releasing hydrazine from the hydrazine-releasable group. Consequently, the hydrazine storage resin can be widely used in various industrial fields requiring supply of hydrazine.

Abstract: To provide an effective factor extraction system in which samples are generated artificially from a sample group and a virtual sample set is created so that even when the number of sample is relatively small, specific factors can be selected/extracted with high reliability by using the virtual sample set. The effective factor extraction system comprises a section for extracting samples arbitrarily from sample sets and creating a plurality of paired virtual sample sets, a statistical quantity operating section for reading out the feature value held by sample contained in respective virtual sample sets and operating the average value and the variance, a section for operating Fisher ratio from the average value and the variance, and a section for testing significant factors using the operated Fisher ratio.

Abstract: The present invention relates to a scoring system for the prediction of cancer recurrence by selecting genes and/or proteins whose expression patterns associated with recurrence of cancer, and generating formulae with the selected genes and/or proteins for the prediction of cancer recurrence. The present invention relates to a kit for determining the likelihood of recurrence of cancer, comprising DNA chip, oligonucleotide chip, protein chip, peptides, antibodies, probes and primers that are necessary for effecting DNA microarrays, oligonucleotide microarrays, protein arrays, northern blotting, in situ hybridization, RNase protection assays, western blotting, ELISA assays, reverse transcription polymerase-chain reaction to examine the expression of at least 2, 4, 6, 10, 12 or more genes and/or proteins, that are indicative of cancer recurrence.

Abstract: To provide an image processor that is capable of presenting images in which a character object is moved smoothly and naturally as a user intends it to be, regardless of the change in shape of an object.

Abstract: A drug effect-adverse effect prediction system includes a clinical data analysis table generating part, for each combination of genotypes relating to a drug effect or adverse effect, for generation of an analysis table for handling cases related to presence or absence of the drug effect or adverse effect. The system also includes a reliability analysis part, a discrimination formula generating part, a prediction part, and a discrimination formula optimizing part.

Abstract: A method for determining the risk of adverse effects of irinotecan (CPT-11), a synthetic anticancer drug, by detecting polymorphisms in the TATA box within the promoter region of the UDP-glucuronosyl transferase gene. A kit for detecting the adverse effects of irinotecan containing at least one pair of nucleic acid probes.